Prosecution Insights
Last updated: August 06, 2026

Chineo Medical Technology Co. Ltd.

3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

2
Hard (67%)
0
Medium (0%)
1
Easy (33%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Double-patenting only1 (33%)
Multi-statute (no §101)2 (67%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
XIAO, YAN 1 67.8% +51.6%
SUNSHINE, HANNAH LOUISE 1 67.7% +14.1%
JOHANSEN, PETER N. 1 59.1% +23.9%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17793771 ENHANCED RECEPTOR FOR IMPROVING IMMUNE CELL FUNCTION SUNSHINE, HANNAH LOUISE 17d overdue
17429835 ADJUVANT CAPABLE OF PROMOTING EXPANSION OF IMMUNE CELLS IN VIVO JOHANSEN, PETER N.

Interview Candidates (3)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
17793771 ENHANCED RECEPTOR FOR IMPROVING IMMUNE CELL FUNCTION SUNSHINE, HANNAH LOUISE 17d overdue
18518539 MODIFIED IMMUNE CELLS AND USES THEREOF XIAO, YAN
17429835 ADJUVANT CAPABLE OF PROMOTING EXPANSION OF IMMUNE CELLS IN VIVO JOHANSEN, PETER N.

Top Art Units

Art UnitApps
1642 1
1647 1
1644 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18518539 MODIFIED IMMUNE CELLS AND USES THEREOF XIAO, YAN 1642 DP Non-Final OA Pending Nov 23, 2023
17793771 ENHANCED RECEPTOR FOR IMPROVING IMMUNE CELL FUNCTION SUNSHINE, HANNAH LOUISE 1647 §102§103§112Other Final Rejection 17d overdue Pending Jan 23, 2023
17429835 ADJUVANT CAPABLE OF PROMOTING EXPANSION OF IMMUNE CELLS IN VIVO JOHANSEN, PETER N. 1644 §102§112 Non-Final OA Pending Mar 21, 2022

Managing Chineo Medical Technology Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month